COVID-19 (omicron JN.1) vaccine is under clinical development by Moderna and currently in Pre-Registration for Coronavirus Disease 2019 (COVID-19).
Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...
The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.
Elasomeran + imelasomeran by Moderna for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Elasomeran + imelasomeran is under clinical development by Moderna and currently in Phase III for Coronavirus Disease 2019 (COVID-19).
Hosted on MSN6d
Feds issue new COVID vaccine guidance, says provinces now responsible for buying themFederal funding for COVID-19 vaccines will stop this year and the provinces and territories will be responsible for buying ...
The Associated Press on MSN13d
5 things we know and still don't know about COVID, 5 years after it appearedThe omicron relative now dominant in the U.S. is called XEC ... health authorities in the U.S. and Britain cleared vaccines ...
Five years after the COVID-19 pandemic hit South Carolina and the U.S., it is still changing health care, from wastewater ...
The omicron relative now dominant in the U.S. is ... health authorities in the U.S. and Britain cleared vaccines made by Pfizer and Moderna. Years of earlier research — including Nobel-winning ...
COVID-19 has continued to claim lives at an average rate of about 900 deaths per week in the U.S. over the past year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback